The US Court of Appeals for the Second Circuit states that direct purchasers of antidiuretic medicine have antitrust standing in patent infringement suit (DDAVP)

Vesala, Juha

Previous article The Maltese Competition Authority finds that the national airline’s decision to reduce the commission payable to travel agents for flight bookings does not fall foul of the rules of fair competition (Federation of Associations of Travel and Tourism Agents / Air Malta) Next article The Portuguese Competition Authority dismisses tying charges following commitments (Sugalidal - Indústrias de Alimentação / Cifo - Sociedade de Fomento Agrícola / Heinz)

16 Oct 2009

The US Court of Appeals for the Second Circuit states that direct purchasers of antidiuretic medicine have antitrust standing in patent infringement suit (DDAVP)

KEYWORDS

Reference

US Court of Appeals for the Second Circuit, DDAVP, Case No. 06-5525-cv, 16 October 2009

2nd Circuit finds DDAVP purchasers stated Walker Process and related claims and had antitrust standing* On 16 October 2009 the Court of Appeals for the Second Circuit held (In re: DDAVP Direct Purchaser Antitrust Litigation) that direct purchasers of desmopressin acetate tablets, sold under the name DDAVP, stated Walker Process and related antitrust claims and had antitrust standing to do so. The Court thus vacated a U.S. District Court (S.D.N.Y.)

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

Juha Vesala
IPR University Center (Helsinki)

Finland 29 contributions 5356 visits

Quotation

Juha Vesala, The US Court of Appeals for the Second Circuit states that direct purchasers of antidiuretic medicine have antitrust standing in patent infringement suit (DDAVP), 16 October 2009, e-Competitions October 2009, Art. N° 58474

Visites 291